Synthesis, anti-amoebic activity and molecular docking simulation of eugenol derivatives against Acanthamoeba sp.

Abid, 2006, Synthesis, characterization and antiamoebic activity of 1-(thiazolo [4, 5-b] quinoxaline-2-yl)-3-phenyl-2-pyrazoline derivatives, Bioorg. Med. Chem. Lett., 16, 2812, 10.1016/j.bmcl.2006.01.116 Ait-Ouazzou, 2011, The antimicrobial activity of hydrophobic essential oil constituents acting alone or in combined processes of food preservation, Innov. Food Sci. Emerg. Technol., 12, 320, 10.1016/j.ifset.2011.04.004 Anjum, 2022, Novel derivatives of eugenol as potent antiinflammatory agents via PPARg agonism: rational design, synthesis, analysis, PPARg protein binding assay and computational studies, RSC Adv., 12, 16966, 10.1039/D2RA02116A Anacarso, I., Sabia, C., de Niederhäusern, S., Iseppi, R., Condò, C., Bondi, M. and Messi, P. (2017) In vitro evaluation of the amoebicidal activity of rosemary (Rosmarinus officinalis L.) and cloves (Syzygium aromaticum L. Merr. & Perry) essential oils against Acanthamoeba polyphaga trophozoites. Natural Product Research, 33(4), 606–611. Ansari, 2015, Metronidazole hydrazone conjugates: design, synthesis, antiamoebic and molecular docking studies, Bioorg. Med. Chem. Lett., 25, 3545, 10.1016/j.bmcl.2015.06.091 Bai, 2022, Antibacterial effect of eugenol on Shigella flexneri and its mechanism, Foods., 11, 2565, 10.3390/foods11172565 Bhutani, 1987, Plant based antiamoebic drugs; Part I. Antiamoebic activity of phenanthroindolizidine alkaloids; common structural determinants of activity with emetine, Planta Med., 53, 532, 10.1055/s-2006-962803 Castellani, 1930, An amoeba found in culture of yeast: preliminary note, Am. J. Trop. Med. Hyg., 33, 160 Cha, 2006, Case 39–2006: A 24-year-old woman with systemic lupus erythematosus, seizures, and right arm weakness, N. Engl. J. Med., 355, 2678, 10.1056/NEJMcpc069030 Choy, 2011, The rule of five for non-oral routes of drug delivery: ophthalmic, inhalation and transdermal, Pharm. Res., 28, 943, 10.1007/s11095-010-0292-6 Cui, 2019, Eugenol inhibits non-small cell lung cancer by repressing expression of NF-κB-regulated TRIM59, Phytother. Res., 33, 1562, 10.1002/ptr.6352 Daniel, 2009, Anti-inflammatory and antinociceptive activities A of eugenol essential oil in experimental animal models, Rev. Bras, 19, 212 de Souza, 2014, Synthesis and in vitro evaluation of antifungal and cytotoxic activities of eugenol glycosides, Med. Chem. Res., 23, 496, 10.1007/s00044-013-0669-2 Devi, 2010, Eugenol (an essential oil of clove) acts as an antibacterial agent against Salmonella typhi by disrupting the cellular membrane, J. Ethnopharmacol., 130, 107, 10.1016/j.jep.2010.04.025 ElGhannam, 2023, Eugenol; effective anthelmintic compound against foodborne parasite Trichinella spiralis muscle larvae and adult, Pathogens., 12, 127, 10.3390/pathogens12010127 Gan, 2021, Synthesis of novel antiviral ferulic acid-eugenol and isoeugenol hybrids using various link reactions, J. Agric. Food Chem., 69, 13724, 10.1021/acs.jafc.1c05521 Goddard, 2017, UCSF ChimeraX: Meeting modern challenges in visualization and analysis, Protein Sci. Grosdidier, 2011, SwissDock, a protein-small molecule docking web service based on EADock DSS, Nucleic Acids Res., 39, 10.1093/nar/gkr366 Hale, 2013, Autophagy: regulation and role in development, Autophagy, 9, 951, 10.4161/auto.24273 Hashim, F., Amin, N.M., 2017. Insights into the prominent effect of mahanimbine on Acanthamoeba castellanii: Cell profiling analysis based on microscopy techniques. In: AIP Conference Proceedings. vol. 1817, no. 11, pp. 030002. Hashim, 2015, Morphological analysis on the toxic effect of manganese on Acanthamoeba sp. isolated from Setiu Wetland, Terengganu: An in vitro study, Procedia Environ. Sci., 30, 15, 10.1016/j.proenv.2015.10.003 Ju, 2020, Analysis of the synergistic antifungal mechanism of eugenol and citral, LWT, 123, 10.1016/j.lwt.2020.109128 Kaufman, 2015, The multiple faces of eugenol. A versatile starting material and building block for organic and bio-organic synthesis and a convenient precursor toward bio-based fine chemicals, J. Braz. Chem. Soc., 26, 1055 Khan, 2006, Acanthamoeba: biology and increasing importance in human health, FEMS Microbiol. Rev., 30, 564, 10.1111/j.1574-6976.2006.00023.x Kim, 2017, CHARMM-GUI ligand reader and modeler for CHARMM force field generation of small molecules, J. Comput. Chem., 38, 1879, 10.1002/jcc.24829 Kusrini, 2016, A novel antiamoebic agent against Acanthamoeba sp.—A causative agent for eye keratitis infection, Spectrochim. Acta A Mol. Biomol. Spectrosc., 153, 714, 10.1016/j.saa.2015.09.021 Kusrini, 2018, Anti-amoebic activity of acyclic and cyclic-samarium complexes on Acanthamoeba, Parasitol. Res., 117, 1409, 10.1007/s00436-018-5814-x Lackner, 2010, Acute granulomatous Acanthamoeba encephalitis in an immunocompetent patient, Neurocrit. Care, 12, 91, 10.1007/s12028-009-9291-z Lane, 2019, The natural product eugenol is an inhibitor of the ebola virus in vitro, Pharm. Res., 36, 1, 10.1007/s11095-019-2629-0 Laskowski, 2011, LigPlot+: Multiple ligand-protein interaction diagrams for drug discovery, J. Chem. Inf. Model., 51, 2778, 10.1021/ci200227u Lipinski, 1997, Experimental and computational approaches to estimate solubility and permeability in drug discovery and development settings, Adv. Drug Deliv. Rev., 23, 3, 10.1016/S0169-409X(96)00423-1 Lorenzo-Morales, 2008, Glycogen phosphorylase in Acanthamoeba spp.: determining the role of the enzyme during the encystment process using RNA interference, Eukaryot. Cell, 7, 509, 10.1128/EC.00316-07 Lorenzo-Morales, 2010, Pathogenicity of amoebae, Exp. Parasitol., 126, 2, 10.1016/j.exppara.2010.05.003 Lorenzo-Morales, 2013, Acanthamoeba keratitis: an emerging disease gathering importance worldwide?, Trends Parasitol., 29, 181, 10.1016/j.pt.2013.01.006 Machado, 2011, Anti-Giardia activity of Syzygium aromaticum essential oil and eugenol: effects on growth, viability, adherence and ultrastructure, Exp. Parasitol., 127, 732, 10.1016/j.exppara.2011.01.011 Marciano-Cabral, 2003, Acanthamoeba spp. as agents of disease in humans, Clin. Microbiol. Rev., 16, 273, 10.1128/CMR.16.2.273-307.2003 Martins, 2016, Antimicrobial and cytotoxic evaluation of eugenol derivatives, Med. Chem. Res., 25, 2360, 10.1007/s00044-016-1682-z Maurya, 2020, Synthesis of eugenol derivatives and its anti-inflammatory activity against skin inflammation, Nat. Prod. Res., 34, 251, 10.1080/14786419.2018.1528585 Mayer, 2011, Amebic encephalitis, Surg. Neurol. Int., 2, 10.4103/2152-7806.80115 Memari, 2017, Pathogenic Acanthamoeba T4 genotype isolated from mucosal tissue of a patient with HIV infection: a case report, Iran. J. Parasitol., 12, 143 Molchanova, 2020, Halogenation as a tool to tune antimicrobial activity of peptoids, Sci. Rep., 10, 14805, 10.1038/s41598-020-71771-8 Nakisah, 2012, Anti-amoebic properties of a Malaysian marine sponge Aaptos sp. on Acanthamoeba castellanii, World J. Microbiol. Biotechnol., 28, 1237, 10.1007/s11274-011-0927-8 Niyyati, 2009, Genotyping of Acanthamoeba isolates from clinical and environmental specimens in Iran, Exp. Parasitol., 121, 242, 10.1016/j.exppara.2008.11.003 O’Boyle, 2011, Open Babel: An Open chemical toolbox, J. Cheminf., 3, 1 Patel, 2010, Synthesis and antimicrobial activity of new 4-thiazolidinone derivatives containing 2-amino-6-methoxybenzothiazole, Saudi Pharmaceut. J., 18, 129, 10.1016/j.jsps.2010.05.002 Pietrucha-Dilanchian, 2012, Balamuthia mandrillaris and Acanthamoeba amebic encephalitis with neurotoxoplasmosis coinfection in a patient with advanced HIV infection, J. Clin. Microbiol., 50, 1128, 10.1128/JCM.06252-11 Rahim, 2017, Synthesis and antibacterial study of eugenol derivatives, Asian J. Chem., 29, 22, 10.14233/ajchem.2017.20100 Raja, 2017, Eugenol derived immunomodulatory molecules against visceral leishmaniasis, Eur. J. Med. Chem., 139, 503, 10.1016/j.ejmech.2017.08.030 Razali, 2020, Characterisation of a catalytic triad and reaction selectivity in the dual mechanism of the catalyse hydride transfer in xylitol phosphate dehydrogenase, J. Mol. Graph. Model., 97, 10.1016/j.jmgm.2020.107548 Schmidt, 2007, New 1, 3-dioxolane and 1, 3-dioxane derivatives as effective modulators to overcome multidrug resistance, Bioorg. Med. Chem., 15, 2283, 10.1016/j.bmc.2007.01.024 Shirwadkar, 2006, Acanthamoeba encephalitis in patient with systemic lupus, India, Emerg. Infect. Dis., 12, 984, 10.3201/eid1206.060087 Siddiqui, 2016, The development of drugs against Acanthamoeba infections, Antimicrob. Agents Chemother., 60, 6441, 10.1128/AAC.00686-16 Teles, 2021, GC-MS characterization of antibacterial, antioxidant, and antitrypanosomal activity of syzygium aromaticum essential oil and eugenol, Evid.-Based Complem. Alternat. Med., 2021, 10.1155/2021/6663255 Van Doorn, 2011, Classes of programmed cell death in plants, compared to those in animals, J. Exp. Bot., 62, 4749, 10.1093/jxb/err196 Vladu, 2020, Spongious fillers based on collagen-hydroxyapatite-eugenol acetate with therapeutic potential in bone cancer, Farmacia, 68, 313, 10.31925/farmacia.2020.2.17 Westmoreland, 2004, Necrotizing meningoencephalitis and pneumonitis in a simian immunodeficiency virus-infected rhesus macaque due to Acanthamoeba, Vet. Pathol., 41, 398, 10.1354/vp.41-4-398 Yoon, 2022, A Study on the Effect of the Substituent against PAK4 Inhibition Using In Silico Methods, Int. J. Mol. Sci., 23, 3337, 10.3390/ijms23063337 Zamli, 2020, Anti-Amoebic Activity of Eugenol Derivatives against Acanthamoeba castellanii, Malaysian J. Chem., 22, 100 Zamli, 2021, Cholinesterase inhibition activity and molecular docking study of eugenol derivatives, Sains Malaysiana., 50, 1037, 10.17576/jsm-2021-5004-14 Zhao, 2021, Unraveling the polypharmacology of a natural antifungal product, eugenol, against Rhizoctonia solani, Pest Manag. Sci., 77, 3469, 10.1002/ps.6400